LON:DOCS Dr. Martens (DOCS) Share Price, News & Analysis → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free DOCS Stock Alerts GBX 88.90 +0.10 (+0.11%) (As of 05:42 AM ET) Add Compare Share Share Today's Range 85.75▼ 90.4550-Day Range 73.75▼ 97.8052-Week Range 72.25▼ 174.70Volume32,124 shsAverage Volume1.14 million shsMarket Capitalization£855.08 millionP/E Ratio889.00Dividend Yield6.75%Price TargetGBX 177.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades Get Dr. Martens alerts: Email Address Dr. Martens MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside99.7% UpsideGBX 177.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.67Based on 4 Articles This WeekInsider TradingAcquiring Shares£44,945 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.72 out of 5 stars 3.3 Analyst's Opinion Consensus RatingDr. Martens has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 177.50, Dr. Martens has a forecasted upside of 99.7% from its current price of GBX 88.90.Amount of Analyst CoverageDr. Martens has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 1.7 Dividend Strength Dividend LeadershipDr. Martens is a leading dividend payer. It pays a dividend yield of 6.71%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthDr. Martens does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Dr. Martens is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 3.1 News and Social Media Coverage News SentimentDr. Martens has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.37 average news sentiment score of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Dr. Martens this week, compared to 2 articles on an average week.Search InterestOnly 7 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows2 people have added Dr. Martens to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dr. Martens insiders have bought more of their company's stock than they have sold. Specifically, they have bought £449.45 in company stock and sold GBX 0 in company stock.Percentage Held by InsidersOnly 4.12% of the stock of Dr. Martens is held by insiders.Percentage Held by Institutions73.83% of the stock of Dr. Martens is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Dr. Martens is 889.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 146.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Dr. Martens is 889.00, which means that it is trading at a more expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 336.05.Price to Earnings Growth RatioDr. Martens has a PEG Ratio of 2.22. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDr. Martens has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsThe AI Defense Stock Set to SoarTo protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.Here's how you can invest >>> About Dr. Martens Stock (LON:DOCS)Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.Read More DOCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesMarch 13, 2024 | insidertrades.comDr. Martens plc (LON:DOCS) Insider Purchases £149.96 in StockMarch 25, 2024 | mirror.co.ukShoppers are raving about "comfy" £25 chunky sandals that similar to Dr MartensMarch 28, 2024 | Behind the Markets (Ad)The Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.March 22, 2024 | msn.comDr Martens boots that are 'so comfortable' slashed to half priceMarch 21, 2024 | msn.comTake a look at the new Dr. Martens x Supreme shoes that can change colorsMarch 21, 2024 | msn.comDr Martens boots that are 'best ever' with 'zero breaking in time' are now half-priceMarch 20, 2024 | sg.style.yahoo.comDr. Martens and Central Saint Martins Award Four Designers Bursaries Based on 1460 Boot CollaborationsMarch 19, 2024 | msn.comDr. Martens and Central Saint Martins Award Four Designers Scholarships Based on 1940 Boot CollaborationsMarch 28, 2024 | Behind the Markets (Ad)The Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.March 18, 2024 | msn.comDr Martens sale sees 'comfortable from first wear' boots that don't need breaking in slashed to £58 from £129March 13, 2024 | yahoo.comDr. Martens for Spring? Don’t Miss These Groundbreaking New Releases That Are More Lightweight and Comfortable Than Ever.February 29, 2024 | msn.comA Guide to the Best Dr. Martens Shoes, Including One Pair Selena Gomez Wears on RepeatFebruary 27, 2024 | msn.comZendaya Said Her Dune 2 Costume Felt Like a Dr. Martens BootFebruary 24, 2024 | nytimes.com‘Mom, You’re Not Grunge Enough’: Olivia Rodrigo Fans Thrash in the DesertFebruary 20, 2024 | msn.comToday's Dr. Martens Flash Sale Includes $99 off Selena Gomez's Spring-Ready Combat BootsFebruary 19, 2024 | uk.finance.yahoo.comThree years on from Dr Martens’ float it may be time to put a toe in the waterFebruary 16, 2024 | theguardian.comFake fur and Dr Martens: the young peer bringing change to the LordsFebruary 16, 2024 | msn.comMolly Martens Corbett, Thomas Martens to be released from prison sooner than originally planned due to court system errorFebruary 3, 2024 | msn.comFestival fashion 101: An insider's top tips for mastering festival style in 2024February 1, 2024 | uk.finance.yahoo.comWhat on earth is going on with this FTSE 250 stock?February 1, 2024 | uk.finance.yahoo.comDown 42% in six months, why are investors putting the boot into this FTSE 250 icon?January 29, 2024 | uk.finance.yahoo.comThis FTSE 250 stock is falling but I reckon it’s a no-brainer buy!January 29, 2024 | msn.comPennsylvania Game Commission tables plan to reintroduce about 300 American MartensJanuary 28, 2024 | msn.comDown 81% since going public, could this iconic FTSE 250 company be a January bargain?January 25, 2024 | theguardian.comDr Martens’ revenue plummets by a fifth as US sales plungeJanuary 25, 2024 | uk.investing.comBootmaker Dr Martens posts 21% drop in revenue after weak DecemberJanuary 25, 2024 | msn.comBootmaker Dr Martens hit by weak December as US sales slideSee More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 2/2 Dividend1/04/2024Dividend Payable2/02/2024Today3/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryN/A Current SymbolLON:DOCS CUSIPN/A CIKN/A Webwww.drmartensplc.com Phone44 12 1415 7047FaxN/AEmployees2,591Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 177.50 High Stock Price TargetGBX 180 Low Stock Price TargetGBX 175 Potential Upside/Downside+99.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.10 Trailing P/E Ratio888.00 Forward P/E Ratio9.07 P/E Growth2.22Net Income£103.20 million Net Margins10.56% Pretax MarginN/A Return on Equity29.07% Return on Assets10.31% Debt Debt-to-Equity Ratio143.48 Current Ratio2.44 Quick Ratio1.13 Sales & Book Value Annual Sales£977.50 million Price / Sales0.87 Cash FlowGBX 6.22 per share Price / Cash Flow14.29 Book ValueGBX 37 per share Price / Book2.40Miscellaneous Outstanding Shares961,850,000Free FloatN/AMarket Cap£854.12 million OptionableNot Optionable Beta-0.02 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Kenneth Wilson (Age 58)CEO & Director Comp: $773kMr. Jon William Mortimore (Age 57)CFO & Director Comp: $503kMr. Onyeije Ogueri Nwokorie (Age 54)Chief Brand Officer Comp: $67kMr. Geert Peeters (Age 58)Chief Operating Officer Mr. Ronald GarricksChief Information OfficerMs. Meg JohnsonChief Marketing OfficerMs. Emily Clare Reichwald (Age 49)Chief People & Sustainability Officer and Company Secretary Mr. Sean O'NeillChief Digital OfficerMr. Derek ChanPresident of APACMr. Adam M. MeekChief Product OfficerMore ExecutivesKey CompetitorsWatches of Switzerland GroupLON:WOSGDalata Hotel GroupLON:DALNext Fifteen Communications GroupLON:NFCTI Fluid SystemsLON:TIFSCairn HomesLON:CRNView All CompetitorsInsidersKenny WilsonBought 163 shares on 3/11/2024Total: £14,996.00 ($92.00/share)Kenny WilsonBought 172 shares on 2/12/2024Total: £14,964.00 ($87.00/share)Jon MortimoreBought 185 shares on 1/11/2024Total: £14,985.00 ($81.00/share)Kenny WilsonBought 164 shares on 12/11/2023Total: £14,924.00 ($91.00/share)Jon MortimoreBought 134 shares on 11/13/2023Total: £15,008.00 ($112.00/share)View All Insider Transactions DOCS Stock Analysis - Frequently Asked Questions Should I buy or sell Dr. Martens stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" DOCS shares. View DOCS analyst ratings or view top-rated stocks. What is Dr. Martens' stock price target for 2024? 2 equities research analysts have issued twelve-month price objectives for Dr. Martens' shares. Their DOCS share price targets range from GBX 175 to GBX 180. On average, they anticipate the company's stock price to reach GBX 177.50 in the next twelve months. This suggests a possible upside of 99.7% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2024? Dr. Martens' stock was trading at GBX 88.60 at the beginning of the year. Since then, DOCS stock has increased by 0.3% and is now trading at GBX 88.90. View the best growth stocks for 2024 here. How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens? Dr. Martens announced a dividend on Saturday, November 30th. Stockholders of record on Thursday, January 4th will be paid a dividend of GBX 1.56 per share on Friday, February 2nd. This represents a yield of 1.36%. The ex-dividend date of this dividend is Thursday, January 4th. The official announcement can be seen at this link. Read our dividend analysis for DOCS. Is Dr. Martens a good dividend stock? Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 6.71%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for DOCS. How do I buy shares of Dr. Martens? Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:DOCS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.